Literature DB >> 3644824

Determination of mevinolin and mevinolinic acid in plasma and bile by reversed-phase high-performance liquid chromatography.

R J Stubbs, M Schwartz, W F Bayne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3644824     DOI: 10.1016/s0378-4347(00)83492-1

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  6 in total

Review 1.  HMG-CoA reductase inhibitors and myotoxicity.

Authors:  M Ucar; T Mjörndal; R Dahlqvist
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

2.  Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase.

Authors:  S Rao; D C Porter; X Chen; T Herliczek; M Lowe; K Keyomarsi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

3.  A Simple Protein Precipitation-based Simultaneous Quantification of Lovastatin and Its Active Metabolite Lovastatin Acid in Human Plasma by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry using Polarity Switching.

Authors:  Ju Wujian; Peng Kuan-Wei; Yang Sihyung; Sun Huijing; Sampson Mario; Wang Michael Zhuo
Journal:  J Chromatogr Sep Tech       Date:  2015-05

4.  Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin.

Authors:  K T Kivistö; T Kantola; P J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  1998-07       Impact factor: 4.335

5.  Variable activation of lovastatin by hydrolytic enzymes in human plasma and liver. 4.

Authors:  B K Tang; W Kalow
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

6.  Interaction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of Lovastatin.

Authors:  Chia-Hao Chen; Yow-Shieng Uang; Shang-Ta Wang; Jyh-Chin Yang; Chun-Jung Lin
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-14       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.